Multiple HPV genotypes in cervical carcinomas: Improved DNA detection and typing in archival tissues

Journal of Clinical Virology

Volumn 29, Issue 4, 2004, Pages 271-276

  Huang, Lee Wen ^a   Chao, Shiouh Lirng ^b   Chen, Pei Hsin ^a   Chou, Hui Ping ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cervical carcinoma; Human papillomavirus; Multiple infections; Polymerase chain reaction (PCR)

Indexed keywords

PRIMER DNA;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; DNA DETERMINATION; DNA FINGERPRINTING; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SUPERINFECTION; TISSUE FIXATION; TISSUE SECTION; TISSUE TYPING; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS STRAIN; WART VIRUS;

EID: 1442359946     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(03)00167-7     Document Type: Article

References (33)

1. Baay M.F., Quint W.G., Koudstaal J., Hollema H., Duk J.M., Burger M.P.et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J. Clin. Microbiol. 34:1996;745-747.
2. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J.et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:1995;796-802.
3. Burger R.A., Monk B.J., Kurosaki T., Anton-Culver H., Vasilev S.A., Berman M.L.et al. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J. Natl. Cancer Inst. 88:1996;1361-1368.
4. Chaouki N., Bosch F.X., Munoz N., Meijer C.J., El Gueddari B., El Ghazi A.et al. The viral origin of cervical cancer in Rabat, Morocco. Int. J. Cancer. 75:1998;546-554.
5. Chichareon S., Herrero R., Munoz N., Bosch F.X., Jacobs M.V., Deacon J. et al. Risk factors for cervical cancer in Thailand: a case-control study. J. Natl. Cancer Inst. 90:1998;50-57.
6. Choo K.B., Pan C.C., Han S.H. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology. 61:1987;259-261.
7. Cullen A.P., Reid R., Campion M., Lorincz A.T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol. 65:1991;606-612.
8. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76:1995;1057-1062.
9. Eluf-Neto J., Booth M., Munoz N., Bosch F.X., Meijer C.J., Walboomers J.M. Human papillomavirus and invasive cervical cancer in Brazil. Br. J. Cancer. 69:1994;114-119.
10. Fife K.H., Cramer H.M., Schroeder J.M., Brown D.R. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J. Med. Virol. 64:2001;550-559.
11. Herrero R., Hildesheim A., Bratti C., Sherman M.E., Hutchinson M., Morales J.et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. 92:2000;464-474.
12. Ho G.Y.F., Bierman R., Beardsley L., Chang C.J., Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:1998;423-427.
13. Jacobs M.V., Snijders P.J., Voorhorst F.J., Dillner J., Forslund O., Johansson B.et al. Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J. Clin. Pathol. 52:1999;498-503.
14. Karlsen F., Kalantari M., Chitemerere M., Johansson B., Hagmar B. Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab. Invest. 71:1994;604-611.
15. Kleter B., van Doorn L.J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M.et al. A novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol. 153:1998;1731-1739.
16. Kleter B., van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J.et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:1999;2508-2517.
17. Koutsky L.A., Holmes K.K., Critchlow C.W., Stevens C.E., Paavonen J., Beckmann A.M.et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327:1992;1272-1278.
18. Liaw K.L., Hildesheim A., Burk R.D., Gravitt P., Wacholder S., Manos M.M.et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J. Infect. Dis. 183:2001;8-15.
19. Lorincz A.T., Reid R., Jenson A.B., Greenberg M.D., Lancaster W., Kurman R.J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:1992;328-337.
20. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., Wolinsky S.M. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells. 7:1989;209-214.
21. Munoz N., Bosch F.X., de Sanjose S., Tafur L., Izarzugaza I., Gili M.et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer. 52:1992;743-749.
22. Ngelangel C., Munoz N., Bosch F.X., Limson G.M., Festin M.R., Deacon J. et al. Causes of cervical cancer in the Philippines: a case-control study. J. Natl. Cancer Inst. 90:1998;43-49.
23. Park J.S., Hwang E.S., Park S.N., Ahn H.K., Um S.J., Kim C.J.et al. Physical status and expression of HPV genes in cervical cancers. Gynecol. Oncol. 65:1997;121-129.
24. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y., Klein R.S.et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/6+ primer systems. J. Clin. Microbiol. 35:1997;1304-1310.
25. Rolon P.A., Smith J.S., Munoz N., Klug S.J., Herrero R., Bosch X.et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int. J. Cancer. 85:2000;486-491.
26. Saiki R.K., Scharf S., Faloona F., Mullis K.B., Horn G.T., Erlich H.A.et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 230:1985;1350-1354.
27. Santos C., Munoz N., Klug S., Almonte M., Guerrero I., Alvarez M.et al. HPV types and cofactors causing cervical cancer in Peru. Br. J. Cancer. 85:2001;966-971.
28. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B.et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:1993;958-964.
29. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A.et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 314:1985;111-114.
30. Schwartz S.M., Daling J.R., Shera K.A., Madeleine M.M., McKnight B., Galloway D.A.et al. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J. Clin. Oncol. 19:2001;1906-1915.
31. Shamanin V., Delius H., de Villiers E.M. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J. Gen. Virol. 75:1994;1149-1156.
32. Tucker R.A., Johnson P.R., Reeves W.C., Icenogle J.P. Using the polymerase chain reaction to genotype human papillomavirus DNAs in samples containing multiple HPVs may produce inaccurate results. J. Virol. Methods. 43:1993;321-333.
33. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V.et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:1999;12-19.